Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies
Fleur A. de Groot, Tim J.A. Dekker, Jeanette K. Doorduijn, Stefan Böhringer, Mirian Brink, Ruben A.L. de Groen, Lorraine M. de Haan, F. J.Sherida H. Woei-A-Jin, Troy Noordenbos, Aniko Sijs-Szabo, Mirjam A. Oudshoorn, King H. Lam, Arjan Diepstra, Liane C.J. te Boome, Valeska Terpstra, Lara H. Bohmer, Alina Nicolae, Eduardus F.M. Posthuma, Lianne Koens, Marc F. DurianJeroen Stavast, Marjolein W.M. van der Poel, Myrurgia Abdul Hamid, Wendy B.C. Stevens, Sjo L.M. van Rooij, Rimke S. Oostvogels, Angelika Mühlebner, Karen J. Neelis, Michiel van den Brand, Thomas Tousseyn, Daan Dierickx, Okke de Weerdt, Aart Beeker, Patty M. Jansen, Marie José Kersten, Josée M. Zijlstra, Martine E.D. Chamuleau, Hendrik Veelken, Jacoline C.E. Bromberg, Marcel Nijland, Joost S.P. Vermaat*
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies'. Together they form a unique fingerprint.